Sonia son-in-law now the target

October 6, 2012

sonia_sun_inlaw

New Delhi, October 6: Continuing with their attack on the ruling establishment, anti-graft campaigners Arvind Kejriwal and Prashant Bhushan on Friday accused Robert Vadra, son-in-law of UPA chairman Sonia Gandhi, of increasing his wealth from a scanty Rs 50 lakh to Rs 300 crore with the help of real estate giant DLF.

“The DLF in return, received favours from the Congress ruled states of Haryana, Delhi and Rajasthan,” the anti-graft activists alleged at a crowded press conference.

An agitated Congress leadership sprang into action and leaders after leaders dismissed it as a “political conspiracy”, while the BJP demanded probe.

“He (Vadra) registered five companies owned exclusively by him and his mother in 2007-2008 with just Rs 50 lakh. These companies together had no income from any legitimate business activity, but received interest free loans of over Rs 65 crore from DLF. With this money, he purchased properties of DLF worth well over Rs 300 crore at the price far below the market value during 2007-2010,” alleged Bhushan.

The activists produced audit reports of the companies submitted to the Registrar of Companies.

“Thus, seven flats in Magnolia apartments in DLF Gurgaon were purchased for a total of Rs 5.2 crore when the market price of each flat at the time of acquisition was over Rs 5 crore and today its price is between Rs 10 and 15 crore per flat. Similarly, a 10,000-sqft apartment in DLF Aralias (Gurgaon) was purchased for Rs 89 lakh. Its market price at the time of purchase in 2010 was Rs 20 crore and today is more than Rs 30 crore.

“Also, a stake of 50 per cent share in DLF-owned hotel in Saket (DLF Hilton Garden Inn) were purchased for Rs 32 crore. Its market value was over Rs 150 crore,” said Bhushan.

“Why did DLF Ltd give him interest free loans? Why did the real estate giant sell him properties at throwaway price?” asked Prashant Bhushan.

“DLF has been given 350 acres of land by Haryana govt for the development of Magnolia project in Gurgaon where Vadra was allocated 7 apartments and has been given various other properties and benefits by the Congress governments in Haryana and Delhi,” he alleged.

“Prima facie the facts show commission of offences under the prevention of corruption act as well offences under the Income Tax Act. Why are these ostensible offenses not being investigated?” asked Kejriwal.

Union Law Minister Salman Khurshid termed the allegations as a “political conspiracy” against the Congress leadership and said that “we know how to give an answer to such allegations and we will give an answer”.

Congress spokesperson Manish Tewari said that such a press conference “on the eve of election in Gujarat and Himachal only proves that they are nothing else but B Team of BJP”.

BJP spokesperson Ravishankar Prasad, told reporters that it is disturbing because the “recipient of benefits is son-in-law of most important family of the country”. He asked: “What is the business of Robert Vadra? How has he made phenomenal rise in three years? How many companies he owns?”

In a statement, the Delhi government said it is “not in the business of allotting land to private entities” and described the allegations as “mischievous and misleading”.

Comments

Add new comment

Coastaldigest.com reserves the right to delete or block any comments.
Coastaldigset.com is not responsible for its readers’ comments.
Comments that are abusive, incendiary or irrelevant are strictly prohibited.
Please use a genuine email ID and provide your name to avoid reject.

After CAA, Centre might bring population control law: Niranjan Jyoti

News Network

March 2,2020

Mathura, Mar 2: Union Minister of state Sadhvi Niranjan Jyoti on Sunday said after the Citizenship (Amendment) Act (CAA), the Centre might bring a population control law.

Jyoti claimed that she has already spoken to Prime Minister Narendra Modi in this regard.

She said she believes that this issue is under the prime minister's consideration and he himself has discussed the importance of bringing this law.

Jyoti arrived here on Sunday to attend a tribute meeting held at Swami Vamdev Jyotirmath in Chaitanya Vihar. Unnao MP Sakshi Maharaj was also present at the event.

"There was a time when abrogation of Article 370 in Jammu and Kashmir was impossible. It was feared that if such thing happens, there will be bloodbath. No one will be hold the national flag in Kashmir. But this government can bring any law in favour of the nation," Jyoti said.

"Now, everyone believes that if Article 370 can be removed...Prime Minister Narendra Modi can bring any law which is important for the country," she added.

Comments

already people are childless. struggling for IVF treatment. no need of population control. it is automatically getting control byu nature.

Add new comment

Coastaldigest.com reserves the right to delete or block any comments.
Coastaldigset.com is not responsible for its readers’ comments.
Comments that are abusive, incendiary or irrelevant are strictly prohibited.
Please use a genuine email ID and provide your name to avoid reject.

After one day pause, Modi govt hikes petrol and diesel prices again

Agencies

June 29,2020

New Delhi, Jun 29: Fuel prices rose on Monday again after a days pause with oil marketing companies increasing the pump price of petrol by 5 paisa and diesel by 13 paisa per litre in Delhi.

In the national capital, petrol price on Monday stood at Rs 80.43 per litre while that of diesel at Rs 80.53 a litre.

With this increase, fuel prices have moved up on 22 of the last 23 days (with no rise on Sunday). Petrol prices, however, were unchanged for an additional day in between after the daily revision based on dynamic pricing was reinstated by OMCs.

Since the daily price revision resumed on June 7, petrol price has increased Rs 9.17 and diesel rose by Rs 11.14 in the national capital. In the other cities the magnitude of increase was similar.

During the past 23 days, the quantum of price hike gradually declined from around 60 paise raise for a few days, immediately post the resumption of daily price revision, to less than 20 paise during the past few days and now even less than 10 paisa per litre.

In a historic development, the price of diesel surged above that of petrol in the national capital during this period. It continues to remain higher even though on Saturday the quantum of petrol price hike was higher than that of diesel.

Officials in oil marketing companies said that it is hard to predict which of the two fuels will be priced higher in the Capital as the gap between the two is almost negligible. But petrol prices have shown more volatility in international markets that may take it ahead once again in coming days.

Apart from Delhi, the retail prices of petrol and diesel have followed the traditional path in other metros with petrol being priced at a premium of between Rs 5 and 8 per litre. The difference between the auto fuel prices in Delhi and other metros is because of the taxation structure.

While both petrol and diesel are at similar levels of taxes (state and centre) in Delhi, it is higher for petrol in many other Indian cities.

Globally diesel is priced a tad higher than petrol. In India too, the base price of diesel is slightly higher than petrol but taxation at central and state levels changed the complexion of retail prices.

If the price of petroleum products and crude hold their positions in global markets, then petrol and diesel prices rise may stop for a longer period and we may even see marginal fall in prices.

Fuel prices have been increasing since June 7 when oil companies began the daily price revision mechanism after a hiatus of 82 days during the lockdown.

Comments

Add new comment

Coastaldigest.com reserves the right to delete or block any comments.
Coastaldigset.com is not responsible for its readers’ comments.
Comments that are abusive, incendiary or irrelevant are strictly prohibited.
Please use a genuine email ID and provide your name to avoid reject.

Serum Institute of India gets nod for phase 2,3 trials of Oxford covid vaccine

Agencies

August 3,2020

The Drugs Controller General of India (DCGI) has given nod to the Serum Institute of India (SII) for conducting phase 2 and 3 human clinical trials of the Oxford University developed Covid-19 vaccine candidate in the country.

Government officials said that the approval for conducting phase 2 and 3 clinical trials by the SII was granted by DCGI Dr V G Somani late Sunday night after a thorough evaluation based on the recommendations of the Subject Expert Committee (SEC) on Covid-19.

"The firm has to submit safety data, evaluated by the Data Safety Monitoring Board (DSMB), to the CDSCO before proceeding to phase 3 clinical trials," a senior official said.

"As per the study design, each subject will be administered two doses four weeks apart (first dose on day one and second dose on day 29) following which the safety and immunogenicity will be assessed at predefined intervals," the official said.

As a rapid regulatory response, the expert panel at the Central Drugs Standard Control Organisation (CDSCO) on Friday, after a detailed deliberation and considering the data generated on the vaccine candidate in phase 1 and 2 of the Oxford University trial, had recommended granting permission for phase 2 and 3 clinical trials of the potential vaccine, 'Covishield', on healthy adults in India, the officials said.

Currently, phase 2 and 3 clinical trials of the Oxford vaccine candidate is going on in the United Kingdom, phase 3 clinical trial in Brazil and phase 1 and 2 clinical trials in South Africa.

The officials said that the SII had submitted a revised proposal on Wednesday after the SEC on July 28, following deliberation over its application, had asked it to revise its protocol for the phase 2 and 3 clinical trials besides seeking some additional information.

The panel had also recommended that the clinical trial sites which have been proposed for the study be distributed across India.

According to the revised proposal by the SII, 1,600 people aged above 18 years will participate in the trials across 17 selected sites, including AIIMS-Delhi, B J Medical College in Pune, Rajendra Memorial Research Institute of Medical Sciences (RMRIMS) in Patna, Post Graduate Institute of Medical Education and Research in Chandigarh, AIIMS-Jodhpur, Nehru Hospital in Gorakhpur, Andhra Medical College in Visakhapatnam and JSS Academy of Higher Education and Research in Mysore.

"According to the application, it would conduct an observer-blind, randomised controlled study to determine the safety and immunogenicity of 'Covishield' on healthy Indian adults," the official said.

The SII, which has partnered with AstraZeneca, for manufacturing the Oxford vaccine candidate for Covid-19 had submitted its first application to the DCGI on July 25 seeking permission for conducting the phase 2 and 3 trials of the potential vaccine.

Initial results of the first two-phases of trials of the vaccine conducted in five trial sites in the UK showed that it has an acceptable safety profile and homologous boosting increased antibody response, sources had said.

To introduce the vaccine, SII, the world's largest vaccine maker by number of doses produced and sold, has signed an agreement to manufacture the potential vaccine developed by the Jenner Institute (Oxford University) in collaboration with British-Swedish pharma company AstraZeneca.

Comments